📈 Stocks
Apnimed IPO Filing Aims to Fund Pivotal Sleep Apnea Drug Study
(1 hour ago)
Apnimed, backed by Japanese drugmaker Shionogi, files IPO to raise capital for Phase 3 trial of oral sleep apnea therapy, targeting a…